MTNR1B SNP*Food Timing Interaction on Glucose Control
NCT03036592 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 889
Last updated 2025-04-16
Summary
The purpose of this investigation is to assess the role of melatonin receptor 1B (MTNR1B) single nucleotide polymorphism (SNP)\*food timing interaction on glucose control in the deleterious effect in a vulnerable population with regular exposure to concurrent high melatonin and food intake as late night eaters (those having dinner within 2.5 h before their usual bed time). With the results from this study, we expect to advance our understanding of the role of endogenous melatonin on glucose metabolism in late night eaters and carriers of the MTNR1B risk allele, with potential implications on the guidelines to mitigate risk of type 2 diabetes in late night eaters and carriers of the MTNR1B risk allele.
Conditions
- Non-Diabetic Disorder of Endocrine Pancreas
Interventions
- BEHAVIORAL
-
Early OGTT
Oral glucose tolerance test using identical mixed 75 gr of glucose under early condition (4 hours before habitual bedtime)
- BEHAVIORAL
-
Late OGTT
Oral glucose tolerance test using identical mixed 75 gr of glucose under late condition (1 hour before habitual bedtime)
Sponsors & Collaborators
-
Universidad de Murcia
lead OTHER
Principal Investigators
-
Purificación Gomez Abellan, PHD · Universidad de Murcia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2020-03-13
- Completion
- 2020-03-13
Countries
- Spain
Study Locations
More Related Trials
-
Individualised Postprandial Glucose Responses in Type 1 Diabetes
NCT05231642 ·Status: COMPLETED ·Phase: NA
-
GLP1R Polymorphisms and Response to GLP1
NCT00588380 ·Status: COMPLETED ·Phase: NA
-
The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D
NCT03246451 ·Status: COMPLETED ·Phase: NA
-
GLP-1 and Oxyntomodulin Release in Relation to Diet in Type 2 Diabetes Patients.
NCT04105608 ·Status: COMPLETED ·Phase: NA
-
The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers
NCT02229487 ·Status: COMPLETED ·Phase: NA
-
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
NCT06725693 ·Status: RECRUITING
-
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
NCT05119179 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion
NCT01030952 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
NCT01185119 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
NCT00256256 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Domperidone (a Prokinetic Agent) on Time in Range in Digestively Asymptomatic Type I Diabetic Patients With Delayed Gastric Emptying (Gastro-TIR)
NCT06695962 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus
NCT00923962 ·Status: COMPLETED ·Phase: NA
-
Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
NCT00832741 ·Status: COMPLETED
-
Effect of Metformin on Lactate Metabolism
NCT00390273 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients
NCT00437918 ·Status: COMPLETED ·Phase: PHASE4
-
Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes
NCT00529048 ·Status: COMPLETED
-
Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment
NCT04177303 ·Status: UNKNOWN ·Phase: PHASE3
-
Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist
NCT03133741 ·Status: COMPLETED ·Phase: NA
-
Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
NCT02960659 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Raclopride-PET/MRT
NCT03637075 ·Status: COMPLETED ·Phase: NA
-
Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects
NCT01665924 ·Status: COMPLETED ·Phase: PHASE1
-
Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?
NCT02280837 ·Status: COMPLETED
-
Endothelial Function in Obese Adolescents
NCT01879033 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Receptor Expression in CHI
NCT03768518 ·Status: UNKNOWN
-
Glucagon Counterregulation in Type 1 Diabetes
NCT03547427 ·Status: TERMINATED ·Phase: NA